TrialJournal of immunotherapy (Hagerstown, Md. : 1997)2012

A novel dendritic cell-based immunization approach for the induction of durable Th1-polarized anti-HER-2/neu responses in women with early breast cancer.

Gary K Koski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.